Introduction
============

Hydrogen peroxide and its descendant reactive oxygen species (ROS) have historically been viewed in biological systems nearly exclusively as oxidants that damage essential biomolecules,[@cit1]--[@cit3] but recent reports have shown that H~2~O~2~ can also perform essential signaling functions at low concentrations.[@cit4],[@cit5] Due to the damage caused by high ROS concentrations, significant efforts have been devoted to developing antioxidants that catalytically reduce ROS and other oxidizing radicals.[@cit6] Catalytic antioxidants require other species to serve as terminal reductants (ascorbate, glutathione, NADH, *etc.*) and, under certain conditions, depletion of endogenous reductants by a catalytic antioxidant can induce, rather than prevent, oxidative stress.[@cit7]--[@cit9] A catalytic antioxidant that could harness H~2~O~2~ or other ROS as terminal reductants, akin to catalase and superoxide dismutase,[@cit10],[@cit11] would preclude adverse oxidative damage.

Mechanistic studies on the Ru-catalyzed aerobic oxidation of alcohols have provided evidence that O~2~ can insert into a Ru--H bond and be subsequently released as H~2~O~2~ ([Scheme 1A](#sch1){ref-type="fig"}, red arrows).[@cit12],[@cit13] The principle of microscopic reversibility[@cit14] therefore dictates that it is mechanistically equivalent for H~2~O~2~ to react with a Ru complex and be subsequently released as O~2~ with concomitant formation of a Ru--H intermediate ([Scheme 1A](#sch1){ref-type="fig"}, blue arrows). In this reaction, H~2~O~2~ is oxidized to O~2~, and the 2e^--^ liberated in this oxidation will be transferred to Ru in the form of a hydride (H^--^) ligand. The forward and reverse reactions, 1,2-insertion of O~2~ into Ru--H (red arrows) and β-hydride elimination (*i.e.*, 1,2-deinsertion of O~2~)[@cit15] from Ru--OOH (blue arrows), proceed through a common transition state. The forward and reverse reactions in Ru--H + O~2~ ⇌ Ru--OOH could alternatively proceed *via* 1,1-insertion and 1,1-deinsertion of O~2~, respectively, but Ru--OOH would need to rearrange to a higher-energy species for this to be mechanistically feasible (*vide infra*).

![(A) 1,2-Insertion of O~2~ into Ru--H (red arrows), its microscopic reverse β-hydride elimination (*i.e.*, 1,2-deinsertion of O~2~) from Ru--OOH (blue arrows), and their common transition state. Structures of (B) **Ru1** and (C) ABTS˙^--^. Net reaction (D) and mechanism (E) for **Ru1**-catalyzed ABTS˙^--^ reduction with an alcohol.](c8sc05418e-s1){#sch1}

Ruthenium complexes comprising H^--^ and O~2~ ligands both bound to the same metal have been previously observed,[@cit16]--[@cit20] which suggests that the formation of a Ru--H intermediate and O~2~ ([Scheme 1A](#sch1){ref-type="fig"}, blue arrows) can, under certain circumstances, be thermodynamically and/or kinetically more favorable than the insertion of O~2~ into the Ru--H bond ([Scheme 1A](#sch1){ref-type="fig"}, red arrows). Alternatively, if direct observation of a Ru--H intermediate produced by deinsertion of O~2~ from Ru--OOH is experimentally infeasible, due to existing at too low of a concentration or for too short of a lifetime, then the presence of Ru--H can be demonstrated inferentially *via* its chemical reactivity.

We recently reported a Ru complex (**Ru1**, [Scheme 1B](#sch1){ref-type="fig"}) that catalyzed the 1e^--^ reduction of ABTS˙^--^ ([Scheme 1C](#sch1){ref-type="fig"}) with biologically-relevant alcohols (ascorbate, glucose, NAD^+^, *etc.*, [Scheme 1D](#sch1){ref-type="fig"}) as terminal reductants.[@cit21],[@cit22] Importantly, ABTS˙^--^ undergoes 1e^--^ reduction at a potential (*E*~1/2~ = +0.68 V *vs.* NHE) comparable to the ROS generated during oxidative stress,[@cit23]--[@cit25] therefore the one-electron redox reactivity of ABTS˙^--^ can thermodynamically approximate the corresponding reactivity of oxidizing species in living systems. Mechanistic studies by us[@cit26] provided evidence that ABTS˙^--^ was reduced by a Ru--H intermediate formed *via* β-hydride elimination from a Ru--alkoxide ([Scheme 1E](#sch1){ref-type="fig"}). Because the individual steps leading up to Ru--H formation are well-understood and ABTS˙^--^ concentration can be quantified at μM levels,[@cit27] we hypothesized that kinetic analysis of **Ru1**-catalyzed ABTS˙^--^ reduction with H~2~O~2~ would reveal if any Ru--H intermediate had formed. Herein we demonstrate that H~2~O~2~ functions as a terminal reductant for **Ru1**-catalyzed ABTS˙^--^ reduction in aerobic, aqueous solution. Moreover, we provide the first mechanistic evidence that H~2~O~2~ can function as an H^--^ donor to generate the Ru--H intermediate that reduces ABTS˙^--^, in a manner consistent with β-hydride elimination (*i.e.*, 1,2-deinsertion of O~2~) from Ru--OOH ([Scheme 1A](#sch1){ref-type="fig"}, blue arrows).

Results and discussion
======================

Peroxide terminal reductant ability is unique to H~2~O~2~
---------------------------------------------------------

By itself, **Ru1** cannot reduce ABTS˙^--^ to ABTS^2--^ in phosphate buffered saline (PBS, pH 7.4),[@cit28] consistent with the fact that a catalyst cannot be consumed or produced by the net reaction ([Fig. 1A(i)](#fig1){ref-type="fig"}). Subsequent addition of H~2~O~2~ caused a decrease in radical absorbance at 734 nm ([Fig. 1A(ii)](#fig1){ref-type="fig"}) accompanied by an increase in absorbance at 340 nm, consistent with the 1 : 1 conversion of ABTS˙^--^ to ABTS^2--^ (Fig. S1[†](#fn1){ref-type="fn"}). In the absence of **Ru1**, the addition of H~2~O~2~ afforded no change in ABTS˙^--^ concentration, which demonstrated that the reactivity of H~2~O~2~ as a reductant was dependent on the catalyst being present. The oxidation of H~2~O~2~ to O~2~ (*E*°′ = --0.28 V at pH 7) by ABTS˙^--^ (*E*~1/2~ = +0.68 V) is thermodynamically favorable,[@cit24],[@cit29] therefore the lack of reactivity between H~2~O~2~ and ABTS˙^--^ in the absence of **Ru1** demonstrated that the reduction of ABTS˙^--^ with H~2~O~2~ is under kinetic control. When H~2~O~2~ was added to a PBS solution containing **Ru1** and ABTS^2--^, no ABTS˙^--^ formation was observed, which indicated that **Ru1** does not exhibit peroxidase-like reactivity and does not convert H~2~O~2~ into other ROS capable of oxidizing ABTS^2--^.

![Plots of relative \[ABTS˙^--^\] *vs.* time which show that **Ru1** by itself does not reduce ABTS˙^--^ in aqueous solution (A--F, i). In PBS solutions containing **Ru1** and ABTS˙^--^, the addition of H~2~O~2~ caused the radical absorbance to decrease (A, ii), but no ABTS˙^--^ reduction occurred following the addition of *t*-Bu~2~O~2~ (B, ii) or *t*-BuOOH (C, ii). In contrast, the addition of H~2~O~2~ to a solution of **Ru1** and ABTS˙^--^ in pure water afforded no radical reduction (D, ii). Although neither *t*-Bu~2~O~2~ (E, ii) nor *t*-BuOOH (F, ii) enabled **Ru1**-catalyzed ABTS˙^--^ reduction, the subsequent addition of H~2~O~2~ (E and F, iii) did produce decreases in radical absorbance. Conditions: \[**Ru1**\]~0~ = 5 μM, \[ABTS˙^--^\]~0~ = 50 μM, \[ABTS^2--^\]~0~ = 100 μM, \[H~2~O~2~\] or \[*t*-Bu~2~O~2~\] or \[*t*-BuOOH\] = 100 μM, PBS (pH 7.4), 25 °C.](c8sc05418e-f1){#fig1}

To test our hypothesis that H~2~O~2~ functioned as the terminal reductant for **Ru1**-catalyzed ABTS˙^--^ reduction *via* β-hydride elimination from a Ru--OOH species (*i.e.*, [Scheme 1A](#sch1){ref-type="fig"}, blue arrows), we explored the reactivity of other peroxides with this system. Di-*tert*-butyl peroxide (*t*-Bu~2~O~2~) cannot react with **Ru1** to form a Ru--peroxo species and, if our hypothesis were correct, should therefore be incapable of serving as the terminal reductant. Gratifyingly, no ABTS˙^--^ reduction occurred following the addition of *t*-Bu~2~O~2~ to **Ru1** and ABTS˙^--^ in PBS ([Fig. 1B(ii)](#fig1){ref-type="fig"}), which validated this expectation. Conversely, *tert*-butyl hydroperoxide (*t*-BuOOH) can form a Ru--peroxo species, *i.e.*, Ru--OOR, but because the distal oxygen carries a *tert*-butyl group instead of a hydrogen atom, β-hydride elimination cannot occur, which would prevent oxidation of the peroxide and therefore preclude reduction of ABTS˙^--^. This expectation was validated with the observation ([Fig. 1C(ii)](#fig1){ref-type="fig"}) that radical absorbance did not decrease when a PBS solution containing **Ru1** and ABTS˙^--^ was treated with *t*-BuOOH, providing evidence that no Ru--H intermediate was generated. This result was also consistent with our previous findings that primary and secondary alcohols (*e.g.*, EtOH, i-PrOH, *etc.*) could function as terminal reductants for **Ru1**-catalyzed ABTS˙^--^ reduction, whereas a tertiary alcohol like *t*-BuOH could not,[@cit22],[@cit26] which reflected the ability (or inability) of the Ru--OR species to undergo β-hydride elimination (*i.e.*, [Scheme 1E](#sch1){ref-type="fig"}).

Addition of H~2~O~2~ to **Ru1** and ABTS˙^--^ in pure H~2~O (instead of PBS) afforded no change in radical absorbance ([Fig. 1D(ii)](#fig1){ref-type="fig"}), which was consistent with our prior observations that a proton acceptor must be present for **Ru1**-catalyzed ABTS˙^--^ reduction to occur and revealed that deprotonation of H~2~O~2~ was an essential step of the catalytic cycle leading up to the formation of the radical reducing species. Although neither *t*-Bu~2~O~2~ nor *t*-BuOOH afforded any decrease in radical absorbance ([Fig. 1E(ii) and F(ii)](#fig1){ref-type="fig"}), the subsequent addition of H~2~O~2~ to PBS solutions containing **Ru1** and either *t*-Bu~2~O~2~ or *t*-BuOOH did result in ABTS˙^--^ reduction ([Fig. 1E(iii) and F(iii)](#fig1){ref-type="fig"}). The absence of ABTS˙^--^ reduction following the addition of *t*-Bu~2~O~2~ or *t*-BuOOH alone was therefore not due to catalyst deactivation, but was instead due to the fact that neither *t*-Bu~2~O~2~ nor *t*-BuOOH could function as terminal reductants. Collectively, these findings provided further evidence that, for ABTS˙^--^ reduction to occur, a Ru--hydroperoxo species must first be formed, which in turn must be capable of undergoing β-hydride elimination to generate the Ru--H intermediate necessary for ABTS˙^--^ reduction.

Reductant ability is not derived from H~2~O~2~ bond homolysis
-------------------------------------------------------------

Notably, the O--O bond dissociation energy (BDE) values for *t*-Bu~2~O~2~ (40.3 kcal mol^--1^) and *t*-BuOOH (46.1 kcal mol^--1^) are both significantly lower than the corresponding value of 49.5 kcal mol^--1^ for H~2~O~2~ ([Fig. 2](#fig2){ref-type="fig"}).[@cit30]--[@cit32] Therefore, if the ability of H~2~O~2~ to reduce ABTS˙^--^ derived from homolytic cleavage of its O--O bond at some point in the mechanism, then the addition of both *t*-Bu~2~O~2~ and *t*-BuOOH should have afforded a decrease in ABTS˙^--^ concentration due to their lower activation barriers of O--O bond homolysis. Likewise, the O--H and O--C BDE values for *t*-BuOOH (84.2 and 73.6 kcal mol^--1^, respectively) were both lower than the value of 87.8 kcal mol^--1^ for the O--H BDE in H~2~O~2~.[@cit33]--[@cit35] Consequently, if the mechanism of ABTS˙^--^ reduction by H~2~O~2~ proceeded through an O--H bond homolysis step, then a decrease in radical absorbance should have occurred following the addition of *t*-BuOOH, given that homolytic cleavage of its O--H and O--C bonds would both have lower activation energies than O--H bond homolysis in H~2~O~2~.

![Bond-dissociation energies (in kcal mol^--1^) for H~2~O~2~, *t*-Bu~2~O~2~, and *t*-BuOOH.](c8sc05418e-f2){#fig2}

Furthermore, if homolysis of an O--O, O--H, or O--C bond in H~2~O~2~, *t*-Bu~2~O~2~, or *t*-BuOOH did occur, it would transiently generate one or more radical species of sufficiently strong oxidizing power (*e.g.*, *E*°′ = +2.32 V for HO˙, +0.89 V for O~2~˙^--^ derived from HO~2~˙ at pH 7, *etc.*) that oxidation of ABTS^2--^ to ABTS˙^--^ (*E*~1/2~ = +0.68 V) would occur.[@cit24],[@cit29] Similarly, although there are examples in the literature in which a Ru complex reacts with H~2~O~2~ or *t*-BuOOH to generate a Ru([iv]{.smallcaps})--, Ru([v]{.smallcaps})--, or Ru([vi]{.smallcaps})--oxo species,[@cit36]--[@cit40] these high-valent Ru--oxo species undergo 1e^--^ or 2e^--^ reduction at potentials significantly higher than the ABTS˙^--^/ABTS^2--^ redox couple.[@cit41]--[@cit43] However, no ABTS˙^--^ formation was observed when PBS solutions containing ABTS^2--^ were treated with H~2~O~2~, *t*-Bu~2~O~2~, or *t*-BuOOH, either in the presence or absence of **Ru1**.

Collectively, the results from the experiments using H~2~O~2~, *t*-Bu~2~O~2~, and *t*-BuOOH provided strong evidence that the mechanism for the **Ru1**-catalyzed reduction of ABTS˙^--^ with H~2~O~2~ does not involve any strongly oxidizing radicals or high-valent Ru--oxo species, but instead proceeds *via* heterolytic cleavage of the O--H bonds.

Reduction by H~2~O~2~ releases O~2~ gas
---------------------------------------

The volume of O~2~ gas evolved from these experiments was too small to measure directly because H~2~O~2~ was consumed from 3.00 mL reaction volumes. For example, reduction of 50 μM ABTS˙^--^ to 50 μM ABTS^2--^ would consume 25 μM H~2~O~2~ (each H^--^ can reduce 2 ABTS˙^--^) and produce 75 nmol of O~2~ (25 μM × 3.00 mL), corresponding to 1.8 μL at 298 K and 1 atm.

When the reaction volume was increased 1000-fold -- when 100 μM H~2~O~2~ was added to a solution of 50 μM ABTS˙^--^ and 5 μM **Ru1** in 3.00 L of PBS -- 1.8 ± 0.1 mL of O~2~ gas (72 ± 2 μmol) were collected, corresponding to a 96 ± 3% theoretical yield (Fig. S2[†](#fn1){ref-type="fn"}). UV/vis spectroscopic analysis of 3.0 mL aliquots taken from this reaction before and 30 min after the addition of H~2~O~2~ (Fig. S3[†](#fn1){ref-type="fn"}) revealed that \[ABTS˙^--^\] had decreased by 44 ± 1 μM (×3.00 L = 132 ± 3 μmol) and \[ABTS^2--^\] had increased by 42 ± 1 μM (×3.00 L = 126 ± 3 μmol).[@cit44] Thus, the consumption of 1.0 equiv. of ABTS˙^--^ was accompanied by the formation of 0.95 ± 0.03 equiv. of ABTS^2--^ and the generation of 0.54 ± 0.02 equiv. of O~2~ gas.

The evolution of O~2~ gas provided additional evidence that no O--O bond cleavage in H~2~O~2~ was occurring during the **Ru1**-catalyzed reduction of ABTS˙^--^ with H~2~O~2~. Furthermore, the release of 1 equiv. of O~2~ for the reduction of every 2 equiv. of ABTS˙^--^ demonstrated that each molecule of H~2~O~2~ functioned as a 2e^--^ reductant, that both O-atoms from H~2~O~2~ ended up in O~2~, and that both H-atoms from H~2~O~2~ ended up (ultimately) as H^+^.

**Ru1** and horseradish peroxidase compete for H~2~O~2~
-------------------------------------------------------

Horseradish peroxidase (HRP) catalytically oxidizes ABTS^2--^ to ABTS˙^--^ using H~2~O~2~ as the terminal oxidant,[@cit45] which provided us with a convenient method to probe the concentrations of ABTS^2--^ and H~2~O~2~ indirectly. To a solution of 5 μM **Ru1** and 50 μM ABTS˙^--^ in PBS ([Fig. 3(i)](#fig3){ref-type="fig"}) was added 20 μM H~2~O~2~, which produced a gradual decrease in \[ABTS˙^--^\] over the course of 45 min ([Fig. 3(ii)](#fig3){ref-type="fig"}). If our hypothesis were correct, that **Ru1**-catalyzes the reduction of ABTS˙^--^ to ABTS^2--^ using H~2~O~2~ as the terminal reductant, then this decrease in \[ABTS˙^--^\] over time should be accompanied by an increase in \[ABTS^2--^\] and a decrease in \[H~2~O~2~\]. The concentration of 20 μM H~2~O~2~ was therefore deliberately chosen to be insufficient to achieve quantitative ABTS˙^--^ reduction, such that when the decrease in \[ABTS˙^--^\] had ceased, the solution would contain ABTS˙^--^, ABTS^2--^, and **Ru1**, but no H~2~O~2~. Addition of 10 nM HRP to this solution produced no increase in ABTS˙^--^ absorbance ([Fig. 3(iii)](#fig3){ref-type="fig"}), which confirmed that all of the H~2~O~2~ had been consumed in the previous step. To determine if this lack of HRP-induced ABTS˙^--^ formation was due to enzyme deactivation, a second 20 μM aliquot of H~2~O~2~ was then added ([Fig. 3(iv)](#fig3){ref-type="fig"}). The resulting gradual increase in \[ABTS˙^--^\] demonstrated that the lack of reactivity in the previous step was due to depletion of the terminal reductant and not enzyme deactivation. Furthermore, the formation of ABTS˙^--^ in [Fig. 3(iv)](#fig3){ref-type="fig"} could only occur if there were ABTS^2--^ present at the end of [Fig. 3(iii)](#fig3){ref-type="fig"}. This, in turn, provided evidence that the decrease in ABTS˙^--^ absorbance observed in [Fig. 3(ii)](#fig3){ref-type="fig"} was caused specifically by the one-electron reduction of ABTS˙^--^ to ABTS^2--^.

![Plot of relative \[ABTS˙^--^\] *vs.* time following the sequential addition of 5 μM **Ru1** (i), 20 μM H~2~O~2~ (ii), 10 nM HRP (iii), 20 μM H~2~O~2~ (iv), and then 50 mM EtOH (v). Conditions: \[ABTS˙^--^\]~0~ = 50 μM, PBS (pH 7.4), 25 °C.](c8sc05418e-f3){#fig3}

The concentration of H~2~O~2~ added in [Fig. 3(iv)](#fig3){ref-type="fig"} was equal to that added in [Fig. 3(ii)](#fig3){ref-type="fig"}, therefore the HRP had access to a sufficient amount of terminal oxidant to oxidize all of the ABTS^2--^ produced during [Fig. 3(ii)](#fig3){ref-type="fig"} and restore the concentration of ABTS˙^--^ to the initial value in [Fig. 3(i)](#fig3){ref-type="fig"}. However, the \[ABTS˙^--^\] in [Fig. 3(iv)](#fig3){ref-type="fig"} reached a plateau 12 min after the addition of H~2~O~2~ that was well below this initial value. The fact that the relative \[ABTS˙^--^\] did not increase back to 100% indicated that some other species was present that was competing with HRP for the H~2~O~2~. Likewise, the plateau in \[ABTS˙^--^\] indicated that ABTS˙^--^ formation and reduction had both ceased, which was consistent with the H~2~O~2~ supply being depleted (*i.e.*, no terminal oxidant available to HRP, no terminal reductant available to **Ru1**). Moreover, the rate of ABTS˙^--^ formation with **Ru1** present (*i.e.*, [Fig. 3(iv)](#fig3){ref-type="fig"}) was significantly slower than when no **Ru1** was present. Collectively, these results provided strong evidence that HRP-catalyzed ABTS^2--^ oxidation, with H~2~O~2~ as the terminal oxidant, and **Ru1**-catalyzed ABTS˙^--^ reduction, with H~2~O~2~ as the terminal reductant, were both occurring simultaneously and then both ceased when all the H~2~O~2~ had been consumed. After this plateau was reached, 50 mM EtOH was then added and produced an immediate decrease in radical absorbance that led to quantitative ABTS˙^--^ reduction within 30 min ([Fig. 3(v)](#fig3){ref-type="fig"}), which demonstrated that **Ru1** was still present and catalytically competent.

β-Hydride elimination from Ru--OOH is proposed mechanism
--------------------------------------------------------

We propose the mechanism for **Ru1**-catalyzed ABTS˙^--^ reduction with H~2~O~2~ is conserved with the previously reported mechanism in which EtOH is the terminal reductant.[@cit26] Addition of **Ru1** to a solution of ABTS˙^--^ and ABTS^2--^ in PBS will result in rapid exchange[@cit46] of the Cl ligand with ABTS^2--^, ABTS˙^--^, and H~2~O ([Scheme 2](#sch2){ref-type="fig"}, orange arrows) to afford \[L~*n*~Ru-A~red~\]^1--^, \[L~*n*~Ru-A~ox~\], and \[L~*n*~Ru-OH~2~\]^1+^, respectively. Because ABTS^2--^ inhibits **Ru1**-catalyzed ABTS˙^--^ reduction by binding to Ru,[@cit26] kinetic experiments were performed with an excess of ABTS^2--^ present to ensure reproducible data. Substitution of ABTS^2--^ in \[L~*n*~Ru-A~red~\]^1--^ (step 1) and ABTS˙^--^ in \[L~*n*~Ru-A~ox~\] (step 2) by H~2~O will also form \[L~*n*~Ru-OH~2~\]^1+^. Exchange of H~2~O for H~2~O~2~ will afford \[L~*n*~Ru-(H~2~O~2~)\]^1+^ (step 3), which will be converted into \[L~*n*~Ru-OOH\] upon H^+^ dissociation to buffer (step 4). The OOH ligand will then undergo β-hydride elimination (*via***TS5**) to release O~2~ and generate \[L~*n*~Ru-H\] (step 5). Although β-hydride elimination from a Ru--OOH species is unknown, the reverse reaction, insertion of O~2~ into a Ru--H bond, is known[@cit12],[@cit13] and proceeds *via* the same transition state structure (*i.e.*, **TS5**). Alternatively, 1,1-deinsertion of O~2~ would also afford a Ru--H intermediate, but \[L~*n*~Ru-OOH\] would first need to rearrange to a higher-energy species (*vide infra*). Computational studies of other \[RuCl(L~2~)(η^6^-cymene)\] complexes (L~2~ = a bidentate ligand) have shown that decreases in cymene hapticity to accommodate additional ligand binding have activation barriers below 19 kcal mol^--1^,[@cit47] which suggests that a similar hapticity decrease in **TS5** would be thermally accessible. Once it has formed, \[L~*n*~Ru-H\] will then be oxidized to \[L~*n*~Ru-H\]^1+^ by ABTS˙^--^, affording ABTS^2--^ (step 6). Dissociation of H^+^ from \[L~*n*~Ru-H\]^1+^, 1e^--^ oxidation of \[L~*n*~Ru\] by ABTS˙^--^, and subsequent coordination of ABTS^2--^ to \[L~*n*~Ru\]^1+^ to restart the catalytic cycle (dashed arrow) will not influence the reaction rate or appear in the rate equation because they occur after the rate determining step. Although these transformations cannot be directly observed, literature precedents suggest that they are feasible under these reaction conditions.[@cit26]

![Proposed mechanism for **Ru1**-catalyzed ABTS˙^--^ reduction with H~2~O~2~. Forward (clockwise) and reverse (counter-clockwise) reactions are colored in green and blue, respectively. Each *K*~n~ or *k*~n~ corresponds to the equilibrium or rate constant, respectively, for the forward reaction in step "*n*" (*i.e.*, step 1 has equilibrium constant *K*~1~, *etc.*). **TS5** is the structure of the transition state for step 5. The dashed arrow includes multiple transformations that occur after the rate-determining steps (see [@cit26]). All complexes shown above are in the Ru^2+^ oxidation state except for \[L~*n*~Ru-H\]^+^, which is Ru^3+^. The spectator ligand set "L~*n*~" comprises the η^6^-cymene and κ^2^-(C,O)-benzimidazolylidene--carboxylate ligands, but their hapticity/denticity may decrease to accommodate binding of additional ligands.](c8sc05418e-s2){#sch2}

If the proposed mechanism is valid, then ABTS˙^--^ reduction can only occur if the Ru--H intermediate has formed, and this Ru--hydride intermediate, in turn, can only form if the OOH ligand on Ru has undergone β-hydride elimination. Within these constraints, an observation that \[ABTS˙^--^\] has decreased thus serves as an indirect indication that a Ru--OOH species has undergone β-hydride elimination and generated a Ru--H intermediate. Although β-hydride elimination from a Ru--OOH species (*i.e.*, step 5) is unknown, the reverse reaction, insertion of O~2~ into a Ru--H bond, is known[@cit12],[@cit13] and proceeds *via* the same transition state (*i.e.*, **TS5**). Furthermore, there are literature examples of Ru complexes that have both hydride and O~2~ ligands bound to the same metal center,[@cit16]--[@cit20] which suggests that the formation of a Ru--H intermediate and O~2~ (*i.e.*, step 5) can be more thermodynamically favorable and/or faster than the reverse reaction (insertion of O~2~ into the Ru--H bond to form a Ru--OOH species) under the appropriate experimental conditions.

Rate law evidence for proposed mechanism
----------------------------------------

To test the validity of our proposed mechanism for **Ru1**-catalyzed ABTS˙^--^ reduction with H~2~O~2~, we derived the general rate law equation for the catalytic cycle presented in [Scheme 2](#sch2){ref-type="fig"} as a function of the initial rate of ABTS˙^--^ reduction (*v*~0~). If the proposed mechanism is valid, *v*~0~ should be equal to the product of the rate constant for step 6 (*k*~6~) times the concentrations of ABTS˙^--^ and \[L~*n*~Ru-H\] (eqn (1)). Utilizing the pre-equilibrium approximation allowed the initial rate of ABTS˙^--^ reduction (*v*~0~) to be expressed as functions of \[ABTS˙^--^\]~0~, \[ABTS^2--^\]~0~, \[H^+^\]~0~, \[H~2~O~2~\]~0~, and \[**Ru1**\]~0~ (eqn (2)--(4); *y* = *v*~0~; *x* = concentration of independent variable; *a*, *b*, and *c* = constants; see eqn (S1)--(S8)[†](#fn1){ref-type="fn"} for full derivation). If the concentrations of all other species are held constant, the relationship between *v*~0~ and \[ABTS˙^--^\]~0~ will follow eqn (2), the relationship between *v*~0~ and \[ABTS^2--^\]~0~ as well as *v*~0~ and \[H^+^\]~0~ will follow eqn (3), and the relationship between *v*~0~*vs.* \[H~2~O~2~\]~0~ will follow eqn (4).

The *v*~0~ values for **Ru1**-catalyzed ABTS˙^--^ reduction with H~2~O~2~ increased non-linearly as the initial ABTS˙^--^ concentration increased, with *v*~0~ tapering off at higher values of \[ABTS˙^--^\]~0~ ([Fig. 4A](#fig4){ref-type="fig"}), and could be successfully fit using eqn (2). Although substrate binding saturation kinetics would produce a similar curve, this phenomenon could be ruled out because previous studies with EtOH as the terminal reductant instead revealed a linear relationship with \[ABTS˙^--^\]~0~.[@cit26] The non-linearity observed with H~2~O~2~ as the terminal reductant could be attributed to competitive binding between ABTS˙^--^ and H~2~O~2~ (steps 2 and 3, [Scheme 2](#sch2){ref-type="fig"}), due to the significantly lower concentrations of terminal reductant employed in the current study (*i.e.*, 100 μM for H~2~O~2~*vs.* 50 mM for EtOH) and its poorer Lewis basicity (p*K*~a~ = 11.6 for H~2~O~2~*vs.* 15.7 for EtOH).[@cit48] With a sufficiently high terminal reductant concentration or metal binding ability, the contribution of step 2 to the mechanism becomes negligible and the overall rate equation simplifies to a linear form. Because the *v*~0~*vs.* \[ABTS˙^--^\] data could be fit using eqn (2), wherein the \[ABTS˙^--^\] term occurs in both the numerator and denominator, the mechanism of ABTS˙^--^ reduction with H~2~O~2~ must involve (i) ABTS˙^--^ dissociation from Ru before \[L~*n*~Ru-H\] can form (consistent with step 2) and in a subsequent process (ii) bimolecular electron-transfer reaction to ABTS˙^--^ from \[L~*n*~Ru-H\] (consistent with step 6).

![Dependence of the initial rate (*v*~0~) of **Ru1**-catalyzed ABTS˙^--^ reduction with H~2~O~2~ on (A) \[ABTS˙^--^\]~0~ = 5, 10, 25, 50, 75, or 100 μM; (B) \[ABTS^2--^\]~0~ = 50, 100, 150, or 200 μM; (C) pH = 7.4, 7.9, 8.4 or 8.9; (D) \[H~2~O~2~\]~0~ = 25, 50, 100, 200 or 400 μM; (E) \[**Ru1**\]~0~ = 1, 2, 3, 4 or 5 μM; (F) *T* = 15, 25, 35 or 45 °C. The data points (\[square tilted open\]) and error bars were determined from the average and standard deviation values obtained from 4 independent experiments performed on 4 different days, and the grey traces represent the model fits generated by eqn (2) (for ABTS˙^--^), eqn (3) (for ABTS^2--^ and H^+^), and eqn (4) (for H~2~O~2~). Conditions: \[**Ru1**\]~0~ = 5 μM, \[ABTS˙^--^\]~0~ = 50 μM, \[ABTS^2--^\]~0~ = 100 μM, \[H~2~O~2~\]~0~ = 100 μM, PBS (pH 7.4), 25 °C.](c8sc05418e-f4){#fig4}

Plots of *v*~0~*vs.* \[ABTS^2--^\]~0~ and *v*~0~*vs.* \[H^+^\]~0~ ([Fig. 4B and C](#fig4){ref-type="fig"}) revealed that *v*~0~ decreased non-linearly with \[ABTS^2--^\]~0~ and \[H^+^\]~0~, respectively, and could each be fit by eqn (3). These results demonstrated that ABTS˙^--^ reduction can only occur after ABTS^2--^ dissociation from Ru (consistent with step 1) and H^+^ dissociation from H~2~O~2~ (consistent with step 4). The lack of ABTS˙^--^ reduction in pure H~2~O (*vide supra*) provided additional support that H^+^ dissociation to solution is essential for reactivity. The plot of *v*~0~*vs.* \[H~2~O~2~\]~0~ ([Fig. 4D](#fig4){ref-type="fig"}) revealed a positive correlation and could be fit using eqn (4), whereby the deviation from linearity at higher concentrations indicated that H~2~O~2~ must bind to Ru at some point prior to ABTS˙^--^ reduction (consistent with step 3). The linear relationship between *v*~0~ and \[**Ru1**\]~0~ ([Fig. 4E](#fig4){ref-type="fig"}) suggested that the observed reactivity was predominantly produced by a mononuclear species, consistent with our previous mechanistic studies.[@cit26]

The Eyring--Polanyi plot ([Fig. 4F](#fig4){ref-type="fig"}) revealed a positive entropy of activation (Δ*S*^‡^ = 25.5 ± 1.9 cal mol^--1^ K^--1^), which indicated disorder was increasing during the rate determining step. This result was consistent with the proposed mechanism, in which a single intermediate, \[L~*n*~Ru-OOH\], fragments into two separate molecules, \[L~*n*~Ru-H\] and O~2~, *via* β-hydride elimination (step 5). Moreover, the Δ*S*^‡^ value observed for ABTS˙^--^ reduction by **Ru1** with H~2~O~2~ fell within the range of values observed for **Ru1** with other terminal reductants (methanol, ethanol, isopropanol, and ethylene glycol, Δ*S*^‡^ = 11.4--32.8 cal mol^--1^ K^--1^) which have previously been shown to generate Ru--H intermediates *via* β-hydride elimination.[@cit26]

Kinetic isotope effect evidence for proposed mechanism
------------------------------------------------------

Our prior mechanistic studies revealed a solvent kinetic isotope effect (KIE) of 1.74 for **Ru1**-catalyzed ABTS˙^--^ reduction, reflecting the role of the solvent, H~2~O, as H^+^ acceptor (or D^+^ acceptor in the case of D~2~O) in step 4.[@cit26] When this solvent KIE was factored out, the ratio of observed rate constants (*k*~obs~) for **Ru1**-catalyzed ABTS˙^--^ reduction with H~2~O~2~ in protio PBS *vs.* D~2~O~2~ in deutero PBS was determined to be 2.10 ± 0.24, which indicated significant O--H/O--D bond breakage was occurring during the rate determining step. Unfortunately, the individual contributions of step 4 (H^+^ dissociation) and step 5 (β-hydride elimination) could not be deconvoluted because D--O--O--H cannot be obtained in pure form and the pertinent Ru intermediates -- L~*n*~Ru--O(D)OH and L~*n*~Ru--O(H)OD -- will undergo H/D exchange in protio and deutero PBS on a faster timescale than **Ru1**-catalyzed ABTS˙^--^ reduction. Therefore, the observed ratio of 2.10 ± 0.24 was treated as the product of the individual O--H/O--D KIE values for step 4 and step 5, and the square root of this ratio was calculated (1.45 ± 0.08) as an averaged approximation of how each step contributed to the overall mechanism (*i.e.*, 1.45 for step 4 and 1.45 for step 5).

Interestingly, this value was nearly identical to the O--H/D KIE of 1.45 measured with NAD^+^.[@cit21] Although H~2~O~2~ and NAD^+^ are structurally dissimilar, their O--H p*K*~a~ values (11.6 for H~2~O~2~ and 11.8 for NAD^+^) are nearly identical,[@cit48],[@cit49] therefore their O--H bond polarizations will be highly conserved. As a result, H/D isotopic substitution in H~2~O~2~ should impact the transition state structure leading to O--H bond breakage to a similar extent as in NAD^+^. The fact that H~2~O~2~ and NAD^+^ afforded nearly identical O--H/O--D KIE values that aligned with their highly similar p*K*~a~ values, despite their significant structural differences, provided further support for the proposed mechanism shown in [Scheme 2](#sch2){ref-type="fig"}.

Evidence for Ru--H intermediate
-------------------------------

The range of suitable experimental conditions under which **Ru1**-catalyzed ABTS˙^--^ reduction with H~2~O~2~ could still occur precluded direct detection of a Ru--H intermediate by ^1^H NMR or IR spectroscopy, or by ESI-MS. No radical reduction occurs in PBS solutions containing more than 20% CH~3~CN, and the maximum concentration attainable for stock solutions of **Ru1** in CH~3~CN is 1 mM, therefore the highest concentration attainable for **Ru1** in the ABTS˙^--^ reduction experiments is 200 μM, which is well below the detection limit of IR spectroscopy.

In addition, the proposed Ru--H intermediate is formed in the rate determining step, and there are 5 other possible Ru-containing species, and both of these factors would cause the concentration of any Ru--H intermediate to be significantly less than 200 μM. Furthermore, ABTS˙^--^ is a paramagnetic species that can broaden or even suppress ^1^H NMR peaks *via* relaxation. It is therefore unsurprising that no Ru--H intermediate could be detected when **Ru1**-catalyzed ABTS˙^--^ reduction with H~2~O~2~ was monitored by ^1^H NMR or IR spectroscopy.

Catalytic organic transformation reactions which proceed through Ru--H intermediates have been studied by mass spectrometry, however these reactions typically employ millimolar catalyst concentrations.[@cit50] Nonetheless, we sought to detect the Ru--H intermediate proposed for the **Ru1**-catalyzed ABTS˙^--^ reduction with H~2~O~2~ using high-resolution Fourier transform mass spectrometry with electrospray ionization (ESI-MS). Because \[L~*n*~Ru-H\] is neutral, it would need to acquire a charge to be detectable, such as by being converted to \[{L~*n*~Ru-H} + H\]^1+^ (*e.g.*, *m*/*z* = 503.1267) *via* protonation. Unfortunately, no peaks corresponding to this exact species were observed. One possibility is that the H^--^ ligand of \[L~*n*~Ru-H\] reacts with H^+^ to release H~2~ gas and thereby afford \[L~*n*~Ru\]^1+^ (*e.g.*, *m*/*z* = 501.1102), a species that was, in fact, observed in positive mode (Fig. S4[†](#fn1){ref-type="fn"}). However, this same species could also be produced by ligand dissociation from other intermediates, such as dissociation of ABTS^2--^ from \[L~*n*~Ru-A~red~\]^1--^, ABTS˙^--^ from \[L~*n*~Ru-A~ox~\], H~2~O from \[L~*n*~Ru-OH~2~\]^1+^, and H~2~O~2~ from \[L~*n*~Ru-(H~2~O~2~)\]^1+^. Moreover, the ability of ESI-MS to detect the formation of \[{L~*n*~Ru-H} + H\]^1+^ was severely hampered by the fact that the **Ru1**-catalyzed ABTS˙^--^ reduction reaction solutions already contained both positively and negatively charged species that would not require ionization, and at much higher concentrations than any un-ionized \[L~*n*~Ru-H\]. The presence of these charged species can cause severe ionization suppression in ESI-MS, significantly reducing the ability of this technique to ionize and detect low-concentration neutral molecules, such as the reaction intermediate \[L~*n*~Ru-H\].

Although the ^1^H NMR, IR, and ESI-MS experiments did not lead to direct observation of \[L~*n*~Ru-H\], the results did not exclude its formation and they were not inconsistent with the indirect evidence for the formation of \[L~*n*~Ru-H\] provided by the UV/vis spectroscopic kinetic experiments. By itself, H~2~O~2~ was incapable of reducing ABTS˙^--^ to ABTS^2--^, which could only occur if **Ru1** was also present. In addition, the ABTS˙^--^ reduction rate was linear with **Ru1** concentration. Collectively, these results indicated that (1) a Ru-containing species functioned as the catalyst and (2) one or more mononuclear Ru-containing species were intermediates in the catalytic cycle.

No ABTS˙^--^ reduction occurred with **Ru1** by itself unless H~2~O~2~ was also present, which demonstrated that H~2~O~2~ was the terminal reductant. The inability of *t*-Bu~2~O~2~ and *t*-BuOOH to reduce ABTS˙^--^ or to oxidize ABTS^2--^ in the presence of **Ru1** provided evidence that the terminal reductant ability of H~2~O~2~ did not involve O--O or O--H bond homolysis and that no oxidizing radicals or high-valent Ru--oxo or Ru--hydroxo species were generated during the catalytic cycle. The non-linear relationship between the ABTS˙^--^ reduction rate and \[H~2~O~2~\] that gradually approached saturation at higher concentrations was consistent with H~2~O~2~ coordinating to Ru before the rate determining step. Likewise, the inverse relationship between the ABTS˙^--^ reduction rate and \[H^+^\] indicated that one H-atom was lost from H~2~O~2~ as H^+^. Collectively, these results demonstrated that (3) a Ru(H~2~O~2~) species must be formed before the rate determining step, (4) H~2~O~2~ only underwent O--H bond breakage and only *via* heterolysis, and (5) that one O--H bond heterolyzed as O^--^ and H^+^. The most likely product of this combination of processes would be a Ru--OOH species.

Others have demonstrated that H~2~O~2~ formation is responsible for the aerobic oxidation of alcohols[@cit12],[@cit13] by and chemotherapeutic activity[@cit51] of Ru-based catalysts, and H~2~O~2~ could only be produced by a Ru--H intermediate if it underwent insertion of O~2~ into the Ru--H bond, which would yield a Ru--OOH species. The microscopic reverse of this reaction is de-insertion of O~2~ from Ru--OOH, in which the H-atom is transferred to Ru as H^--^ and the O--O single bond is converted to a double bond. The observation that 1 equiv. of O~2~ gas was released for every 2 equiv. of ABTS˙^--^ reduced to 2 equiv. of ABTS^2--^ provided evidence that deinsertion of O~2~ was indeed occurring. The large positive Δ*S*^‡^ value observed for **Ru1**-catalyzed ABTS˙^--^ reduction with H~2~O~2~ demonstrated an increase in disorder during the rate determining step, which would be consistent with the fragmentation of one ligand into multiple ligands (regardless of whether these ligands remained bound to or subsequently dissociated from Ru).

It is important to note that de-insertion of O~2~ from Ru--OOH could proceed *via* 1,1-deinsertion of O~2~, rather than β-hydride elimination (*i.e.*, 1,2-deinsertion of O~2~), and still yield a positive Δ*S*^‡^ value. For 1,1-deinsertion to occur, however, the atom connectivity in \[L~*n*~Ru-OOH\] would need to rearrange to \[L~*n*~Ru-O(O)H\]. The possible structures for \[L~*n*~Ru-O(O)H\] (**IVa** and **IVb**) would be expected to be higher in energy than \[L~*n*~Ru-OOH\]: both are formally charge-separated species, and **IVb** would contain a protonated O~2~ ligand ([Fig. 5](#fig5){ref-type="fig"}). As a result, any equilibrium between \[L~*n*~Ru-OOH\] and **IVa** or **IVb** would be expected to favor \[L~*n*~Ru-OOH\]. Similarly, dissociation of H^+^ from \[L~*n*~Ru(H~2~O~2~)\] would be expected to occur preferentially at the OH group directly bound to Ru, which would yield \[L~*n*~Ru-OOH\], rather than at the other OH group, which would yield **IVa**. Although 1,1-deinsertion and β-hydride elimination (*i.e.*, 1,2-deinsertion) would both afford large, positive values for Δ*S*^‡^, we believe that β-hydride elimination is more probable than 1,1-deinsertion of O~2~ because it represents a lower-energy pathway.

![β-Hydride elimination (*i.e.*, 1,2-deinsertion of O~2~) could proceed from \[L~*n*~Ru-OOH\], whereas 1,1-deinsertion would first require rearrangement to a different form, such as **IVa** or **IVb**.](c8sc05418e-f5){#fig5}

The lack of reactivity with *t*-BuOOH provided evidence that the reduction of ABTS˙^--^ with H~2~O~2~ did not involve either heterolytic or homolytic cleavage of the O--O bond, because the activation barriers for these transformations would be lower for *t*-BuOOH than for H~2~O~2~ and they would generate intermediates capable of oxidizing ABTS^2--^. Furthermore, the evolution of O~2~ gas provided additional evidence that the O--O bond in H~2~O~2~ is not broken heterolytically or homolytically. With these constraints, the only way an HOO^--^ ligand on Ru could fragment into multiple species and be accompanied by the release of O~2~ gas would be *via* breakage of the O--H bond. Moreover, the only way this O--H bond could break that would be consistent with the fact that H~2~O~2~ must be oxidized to be able to serve as terminal reductant for **Ru1**-catalyzed ABTS˙^--^ reduction would be if this O--H bond broke heterolytically to afford O~2~. Consequently, the fragmentation of an HOO^--^ ligand to generate O~2~ could only occur if H^--^ was also generated. Indeed, for every 2 equiv. of ABTS˙^--^ reduced to 2 equiv. of ABTS^2--^ by H~2~O~2~, 1 equiv. of O~2~ gas was released, indicating that H~2~O~2~ functions as a 2e^--^ reductant in this reaction through its H-atoms. Because the two O-atoms are lost from H~2~O~2~ as O~2~ and one H-atom is lost as H^+^, the other H-atom must carry the 2e^--^ for reducing 2 equiv. of ABTS˙^--^, which would most likely occur in the form of a hydride (H^--^).

Because Ru complexes comprising both H^--^ and O~2~ ligands have been sufficiently stable to be characterizable by single-crystal X-ray diffraction,[@cit16]--[@cit20] β-hydride elimination from an HOO^--^ ligand can be sufficiently thermodynamically favorable to drive the conversion of Ru--OOH to Ru--H. Moreover, the Δ*S*^‡^ value observed with H~2~O~2~ fell within the range of values observed with non-tertiary alcohol-based terminal reductants that were also shown to proceed through β-hydride elimination transition states. Collectively, these findings provide evidence that (6) the oxidation of H~2~O~2~ to O~2~, which supplies the electrons necessary for ABTS˙^--^ reduction, must occur *via* elimination of H^--^ from an HOO^--^ ligand. The most probable destination of any H^--^ eliminated from an HOO^--^ ligand bound to Ru would be that same metal center, the product of which would be a Ru--H intermediate.

Summary and conclusions
=======================

Our findings demonstrate that (i) a mononuclear Ru-containing species is the catalyst for ABTS˙^--^ reduction, (ii) H~2~O~2~ is the terminal reductant, (iii) H~2~O~2~ is a 2e^--^ reductant, (iv) H~2~O~2~ coordinates to Ru before the rate determining step, (v) the two O-atoms from H~2~O~2~ depart as O~2~ gas, and (vi) the two H-atoms from H~2~O~2~ depart as H^+^ and H^--^. Although the experimental constraints of the ABTS˙^--^ reduction reaction were ultimately incompatible with direct observation of any Ru--H intermediate by ^1^H NMR, IR, or ESI-MS, the mechanism presented in [Scheme 2](#sch2){ref-type="fig"} (with the caveat that the conversion of Ru--OOH to Ru--H could proceed *via* either β-hydride elimination or 1,1-deinsertion of O~2~) properly accounts for all of the aforementioned findings and provides a general rate law that accurately models all of the UV/vis spectroscopy kinetic data.

This report constitutes, to the best of our knowledge, both (i) the first instance of H~2~O~2~ functioning as a terminal reductant under biologically-relevant conditions and (ii) the first instance of H~2~O~2~ functioning as a hydride donor. However, the ability of H~2~O~2~ to function as both an oxidant and reductant is not unprecedented and, in fact, serves as the basis for H~2~O~2~ fuel cells.[@cit52],[@cit53] Given the impressive advances using H~2~O~2~ as an oxidant in green catalysis,[@cit54]--[@cit57] the newfound ability of H~2~O~2~ to function as an H^--^ donor and reductant (the byproduct of which is O~2~) will lead to complementary advances using H~2~O~2~ as a green H^--^ donor and reductant. Furthermore, establishing the proof-of-principle that H~2~O~2~ can act as an H^--^ donor in a chemical reaction (*i.e.*, reduction of ABTS˙^--^ to ABTS^2--^) provides the foundation for future discoveries of biological reactions in which H~2~O~2~ acts as an H^--^ donor in living systems. The ability of **Ru1** to reduce oxidizing species using H~2~O~2~ as the terminal reductant under biologically-relevant conditions provides a strong impetus to investigate the therapeutic efficacy of **Ru1** in maintaining cellular redox homeostasis or modulating essential cellular redox processes. The findings of our efforts in these areas will be detailed in a future report.
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